cytotox
lymphocyt
ctl
play
import
role
antivir
immun
sever
human
hlaa
restrict
ctl
epitop
sever
acut
respiratori
syndrom
sar
spike
protein
identifi
hlaa
transgen
tg
mice
mechan
properti
immun
respons
still
well
understood
studi
hlaa
tg
mice
prime
intramuscularli
sar
dna
boost
subcutan
hlaa
restrict
peptid
lymphocyt
drain
lymph
node
spleen
lung
stimul
cognat
peptid
three
differ
method
elisa
elispot
fac
use
evalu
immun
respons
short
long
period
time
immun
result
show
peptidespecif
cell
secret
express
cell
surfac
cell
cell
distribut
throughout
lymphoid
nonlymphoid
tissu
frequenc
peptidespecif
cell
higher
lung
spleen
lymph
node
phenotyp
cell
character
base
express
hlaa
restrict
peptidespecif
cell
repres
memori
subset
high
low
taken
togeth
data
demonstr
immun
sar
dna
hlaa
restrict
peptid
elicit
antigenspecif
cell
immun
respons
may
signific
implic
longterm
protect
provid
novel
inform
cellular
immun
respons
sar
antigenspecif
cell
import
develop
vaccin
sarscov
infect
sever
acut
respiratori
syndrom
sar
emerg
infecti
diseas
caus
novel
coronaviru
name
sarsassoci
coronaviru
sarscov
led
thousand
infect
patient
hundr
death
date
effect
drug
prevent
treat
sar
addit
possibl
reintroduct
sarslik
coronaviru
human
risk
escap
sarscov
laboratori
although
outbreak
seem
sar
remain
safeti
concern
sarscov
isol
genom
sequenc
sarscov
positivesens
rna
viru
consist
four
main
structur
protein
spike
protein
membran
protein
envelop
protein
e
nucleocapsid
protein
n
protein
major
structur
glycoprotein
sarscov
respons
receptor
bind
membran
fusion
report
vaccin
base
protein
seem
provid
protect
via
inhibit
viral
replic
challeng
live
sarscov
addit
cellmedi
respons
induc
protein
also
play
import
role
elimin
viru
demonstr
previous
immun
sarscov
dna
vaccin
cellular
immun
induc
evid
high
frequenc
produc
effectormemori
cell
mice
henc
protein
major
target
develop
antisar
drug
vaccin
evid
suggest
cytotox
lymphocyt
ctl
play
pivot
role
elimin
viru
particl
infecti
bronchiti
viru
ibv
acut
infect
respiratori
syncyti
viru
rsv
infect
ctl
contribut
viru
elimin
also
induc
immunopatholog
excit
us
found
sarscov
specif
ctl
respons
detect
patient
recov
sar
mous
model
therefor
ctl
may
determin
role
immun
control
viral
pathogenesi
human
ctl
specif
peptid
present
context
major
histocompat
complex
mhc
class
molecul
hlaa
express
major
ethnic
furthermor
hla
class
allel
report
correl
sar
suscept
recent
five
proteinderiv
ctl
epitop
identifi
group
screen
hlaa
restrict
peptid
may
appropri
vaccin
candid
howev
phenotyp
characterist
function
ctl
induc
hlaa
restrict
peptid
remain
undefin
distribut
differ
organ
still
unknown
studi
cell
respons
induc
hlaa
restrict
peptid
evalu
drain
lymph
node
spleen
lung
hlaa
transgen
mice
vaccin
sarscov
dna
prime
hlaa
restrict
peptid
boost
strategi
function
characterist
cognat
peptid
induc
cell
respons
analyz
data
confirm
previou
report
demonstr
numer
power
peptidespecif
cell
repres
memori
subset
high
low
elicit
hlaa
peptid
lymphoid
nonlymphoid
tissu
peptidespecif
cell
persist
long
period
time
suggest
longterm
protect
effect
vivo
data
provid
novel
inform
antigenspecif
cell
respons
detail
could
use
design
effect
vaccin
sarscov
infect
human
hlaa
b
transgen
tg
mice
gift
prof
yz
wu
institut
immunolog
third
militari
medic
univers
chongq
china
tg
mice
bred
pathogenfre
facil
cell
surfac
hlaa
express
assess
flow
cytometri
use
fitclabel
antihuman
ab
bd
bioscienc
pharmingen
experiment
purpos
sixeightweekold
femal
mice
use
experi
perform
accord
guidelin
institut
anim
committe
tmmu
plasmid
encod
sarscov
protein
construct
describ
kindli
provid
dr
gari
j
nabel
vaccin
research
center
vrc
nation
institut
allergi
infecti
diseas
niaid
nation
institut
health
nih
bethesda
md
usa
plasmid
dna
purifi
plasmid
purifi
kit
qiagen
usa
ratio
rang
endotoxin
content
purifi
plasmid
dna
detect
uml
endotoxin
level
within
rang
effect
immun
respons
sequenc
potenti
hlaa
peptid
within
sarscov
protein
base
strain
sarscov
genbank
access
combin
two
comput
algorithm
first
computerbas
program
appli
access
websit
bioinformat
molecular
analysi
section
bima
hla
peptid
bind
predict
second
algorithm
syfpeithi
develop
rammense
et
al
besid
accord
inform
sever
publish
articl
report
screen
synthes
five
peptid
name
vvflhvtyv
ilpdplkpt
rlnevaknl
vlndilsrl
klpddfmgcv
sangon
crop
shanghai
china
peptid
purifi
revers
phase
hplc
confirm
mass
spectrometri
dissolv
pb
mgml
store
aliquot
c
hlaa
b
tg
mice
wellestablish
model
studi
hlaa
restrict
ctl
epitop
vaccin
develop
mice
inject
intramuscularli
g
truncat
sar
cov
plasmid
dna
l
pb
thigh
two
week
later
mice
boost
subcutan
inject
hlaa
restrict
peptid
g
g
cpg
odn
sangon
crop
shanghai
china
adjuv
base
tail
pb
administr
alon
control
experi
repeat
time
consist
result
mice
use
experi
media
purchas
gibco
supplement
heatinactiv
fc
uml
penicillin
gml
streptomycin
purifi
antimous
isotyp
control
ab
purchas
bd
bioscienc
pharmingen
recombin
murin
gmcsf
obtain
r
peprotech
inc
usa
respect
lp
provid
sigma
usa
mice
sacrif
lymph
node
spleen
lung
individu
mous
harvest
boost
vaccin
singlecel
suspens
prepar
bone
marrow
deriv
dc
gener
tg
mice
previous
describ
modif
dc
puls
pool
peptid
gml
peptid
c
h
cocultur
lymphocyt
lymphocyt
suspens
lymph
node
spleen
lung
plate
respect
microtit
plate
l
per
well
presenc
peptideload
dc
supernat
cell
cultur
collect
h
later
level
assess
respect
specif
elisa
kit
bd
pharmingen
accord
manufactur
protocol
assay
perform
use
mous
elispot
set
bd
pharmingen
accord
instruct
provid
manufactur
briefli
singlecel
suspens
vaccin
mice
prepar
plate
well
micropl
millipor
precoat
antibodi
overnight
c
block
contain
fb
cell
incub
h
presenc
absenc
peptideload
dc
c
co
well
wash
incub
biotinyl
label
antimous
antibodi
h
room
temperatur
wash
well
incub
streptavidin
conjug
horseradish
peroxidas
h
room
temperatur
well
extens
wash
develop
aec
substrat
solut
dri
well
count
tcl
elispot
reader
usa
singlecel
suspens
lymph
node
spleen
lung
vaccin
mice
cocultur
without
peptideload
dc
h
c
co
brefeldin
gml
sigma
ad
last
h
incub
cell
wash
fix
paraformaldehyd
permeabil
pb
buffer
contain
saponin
sigma
bsa
nan
overnight
c
cell
stain
conjug
mab
surfac
marker
intracellular
cytokin
min
c
dark
cell
acquir
flow
cytomet
bd
calibur
data
analyz
program
flowjo
version
tree
star
inc
usa
isotyp
control
includ
stain
statist
evalu
differ
mean
experiment
group
perform
analysi
varianc
nonparametr
twotail
test
valu
p
consid
signific
assess
product
cytokin
lymphocyt
tg
mice
follow
sarscov
dna
prime
hlaa
restrict
peptid
boost
vaccin
hlaa
b
tg
mice
randomli
divid
three
group
immun
cognat
dna
plu
peptid
dna
alon
pb
control
respect
boost
vaccin
mice
sacrif
cell
prepar
lymph
node
spleen
lung
cell
stimul
without
peptideload
dc
assess
hlaa
restrict
peptidespecif
immun
respons
level
cellfre
cultur
supernat
determin
elisa
result
reveal
low
level
detect
lymphocyt
cultur
medium
alon
interestingli
addit
peptideload
dc
cell
cultur
system
markedli
enhanc
product
organ
dna
plu
peptid
immun
mice
fig
modest
product
splenocyt
dna
alon
immun
mice
p
level
pb
control
group
undetect
besid
produc
lymphocyt
tg
mice
immun
sar
dna
hlaa
restrict
peptid
follow
cognat
peptid
stimul
vitro
result
show
highest
level
detect
lung
nonlymphoid
tissu
p
product
spleen
p
lymph
node
p
littl
stronger
lung
fig
taken
togeth
data
indic
strike
cytokin
product
induc
lymphoid
nonlymphoid
lymphocyt
stimul
hlaa
restrict
peptid
tg
mice
follow
sar
dna
plu
hlaa
restrict
peptid
vaccin
detect
product
total
lymphocyt
elisa
howev
percentag
hlaa
restrict
peptidespecif
cell
induc
tg
mice
dna
plu
peptid
immun
thu
frequenc
cell
singl
cell
level
determin
elispot
assay
shown
fig
prime
immun
sar
dna
boost
immun
hlaa
restrict
peptid
cell
spleen
produc
averag
spot
cell
follow
stimul
peptideload
dc
compar
cell
without
peptid
stimul
specif
cell
exhibit
increas
frequenc
cell
spleen
p
togeth
believ
hlaa
restrict
peptid
could
act
stimul
induc
power
peptidespecif
cell
immun
respons
directli
character
subpopul
cell
next
analyz
immun
respons
cell
subset
induc
prime
boost
immun
tg
mice
fac
splenocyt
stimul
vitro
without
peptideload
dc
presenc
brefeldin
stimul
h
cellsurfac
marker
intracellular
cytokin
stain
isotyp
control
flow
cytometr
analysi
lymphocyteenrich
popul
initi
select
total
cell
forwardsid
scatter
gate
fig
express
subpopul
analyz
respect
hlaa
restrict
peptid
specif
cell
detect
subset
cell
result
consist
previou
report
identifi
peptid
hlaa
restrict
peptid
base
product
percentag
peptidespecif
cell
peptid
stimul
markedli
higher
cell
cultur
medium
alon
fig
data
suggest
hlaa
restrict
peptid
could
act
stimul
elicit
strike
peptidespecif
ctl
respons
evid
confirm
larg
amount
ctl
induc
peptid
furthermor
want
know
kind
cytokin
could
produc
ctl
illumin
question
splenocyt
primeboost
immun
mice
stimul
vitro
without
peptideload
dc
way
ctl
relat
intracellular
cytokin
stain
isotop
control
result
show
hlaa
restrict
peptidespecif
ctl
could
simultan
produc
sever
kind
cytokin
fig
analysi
express
demonstr
peptidespecif
ctl
could
divid
three
distinct
subpopul
includ
cell
cell
cell
cell
express
small
subset
cell
express
either
alon
fig
b
experi
express
present
phenomenon
peptidespecif
ctl
could
separ
doubl
posit
subset
singl
posit
singl
posit
subset
differ
mainli
subset
compos
singl
posit
cell
small
popul
cell
could
detect
cell
observ
fig
taken
togeth
result
indic
hlaa
restrict
peptidespecif
ctl
elicit
vivo
produc
sever
kind
cytokin
follow
peptid
stimul
suggest
ctl
may
effect
function
protect
bodi
infect
character
phenotyp
hlaa
restrict
peptidespecif
cell
basi
abil
produc
splenocyt
primeboost
immun
tg
mice
stimul
peptideload
dc
h
incub
cell
harvest
wash
stain
cellsurfac
marker
includ
marker
memori
cell
mice
effectormemori
subset
marker
cell
first
gate
cell
phenotyp
cell
analyz
shown
fig
nearli
cell
express
high
approxim
subset
low
although
produc
cell
high
low
cell
variabl
fraction
mean
valu
cell
express
high
level
consid
typic
central
memori
cell
thu
basi
produc
cell
popul
peptidespecif
cell
characterist
memori
cell
identifi
studi
cell
high
low
might
inde
belong
intermedi
sub
set
readi
conscript
effector
popul
reinfect
interest
determin
whether
number
cytolyt
effector
cell
induc
hlaa
restrict
peptid
know
degranul
key
step
agspecif
cell
lyze
target
cell
evid
suggest
fac
assay
measur
exposur
onto
cell
surfac
result
degranul
present
membran
cytotox
granul
observ
reciproc
express
surfac
may
due
granzym
deplet
cell
undergon
recent
granul
exocytosi
studi
surfac
express
enrich
cell
stimul
peptid
vitro
popul
cell
without
peptid
stimul
fig
time
express
cell
determin
result
show
small
part
cell
coexpress
suggest
divers
antigenspecif
cell
thu
subset
cell
express
effector
molecul
associ
cytotox
function
believ
data
strongli
support
hypothesi
antigenspecif
cell
mediat
effect
cytotox
activ
vivo
ascertain
whether
distribut
hlaa
restrict
peptidespecif
cell
distinct
differ
organ
tg
mice
immun
sar
dna
peptid
inject
peptidespecif
cell
base
express
determin
lymph
node
spleen
lung
shown
fig
percentag
produc
cell
total
lymphocyt
differ
organ
dramat
higher
cultur
medium
alon
highest
frequenc
antigenspecif
express
cell
well
produc
cell
elicit
hlaa
restrict
peptid
stimul
lung
lymph
node
spleen
fig
result
suggest
effector
cell
alway
exist
nonlymphoid
tissu
consist
previou
report
previou
experi
evalu
peptidespecif
cell
immun
respons
prime
boost
vaccin
extend
studi
character
sar
hlaa
restrict
peptidespecif
longpersist
memori
cell
respons
boost
immun
data
show
persist
peptidespecif
memori
cell
could
secret
follow
cognat
peptid
stimul
still
could
detect
spleen
though
one
month
past
sinc
boost
vaccin
frequenc
mean
valu
cell
cell
mean
valu
stimul
splenocyt
higher
cell
cultur
medium
alon
respect
similar
result
also
obtain
peptidespecif
cell
coexpress
possess
great
percentag
suggest
strong
abil
peptidespecif
cell
induc
sar
hlaa
restrict
peptid
addit
base
product
phenotyp
longliv
peptidespecif
cell
character
surfac
marker
major
cell
high
low
constel
find
make
us
believ
peptidespecif
cell
induc
primeboost
vaccin
quickli
conscript
effector
popul
protect
bodi
reinfect
fig
gener
memori
cell
potenti
strategi
design
vaccin
intracellular
pathogen
report
vaccin
cytotox
lymphocyt
epitop
could
protect
human
metapneumoviru
infect
murin
model
suggest
ctl
play
pivot
role
viru
elimin
studi
properti
immun
respons
ctl
induc
sar
hlaa
restrict
peptid
vaccin
hlaa
tg
mice
explor
found
ctl
gener
respons
sar
dna
prime
hlaa
restrict
peptid
boost
immun
secret
furthermor
detect
ctl
express
cell
surfac
first
time
repres
cytolyt
activ
cell
peptidespecif
hlaa
manner
final
result
show
peptidespecif
cell
keep
longterm
surviv
vivo
memori
cell
phenotyp
base
low
express
high
level
distribut
lymphoid
tissu
nonlymphoid
tissu
differ
spike
protein
major
structur
glycoprotein
sarscov
understand
immunolog
coronaviru
infect
mice
swine
indic
larg
number
potenti
vaccin
antigen
encod
sarscov
genom
glycoprotein
would
best
recent
work
shed
light
import
role
protein
induc
effect
cellular
immun
respons
humor
respons
mice
human
previou
studi
demonstr
primeboost
vaccin
mice
sarscov
dna
vaccin
induc
remark
antigenspecif
cellular
humor
immun
respons
respons
pool
entir
overlap
peptid
view
advantag
polypeptid
vaccin
mani
team
tri
identifi
sar
epitop
provid
optimum
candid
vaccin
develop
identifi
two
novel
epitop
could
induc
antigenspecif
cell
cell
immun
respons
bablc
mice
respect
howev
known
ultim
purpos
scientif
research
use
human
be
although
mani
antigenspecif
cell
epitop
sarscov
identifi
anim
model
appropri
directli
appli
human
vaccin
identif
function
domin
cell
epitop
sarscov
protein
human
crucial
excit
us
sever
hlaa
restrict
peptid
sar
protein
screen
group
current
howev
mechan
properti
immun
respons
induc
epitop
still
well
understood
present
studi
verifi
result
determin
function
featur
peptidespecif
cell
elicit
hlaa
restrict
peptid
consist
perviou
report
express
lung
higher
lymph
node
spleen
suggest
effector
cell
transient
endow
abil
traffic
nonlymphoid
organ
addit
antigenstimul
cell
acquir
antivir
effector
function
abil
produc
import
effect
role
activ
macrophag
induc
apoptosi
infect
cell
contribut
granuloma
format
littl
direct
effect
function
indic
cell
higher
capac
surviv
prolifer
later
evolv
effect
respons
although
peptidespecif
cell
lymph
node
spleen
could
produc
upon
peptid
stimul
level
lung
detect
know
antigenspecif
cell
becom
exhaust
loss
subset
effect
function
product
appear
sensit
inactiv
follow
synthesi
product
appear
resist
earli
function
loss
say
word
cell
produc
also
like
differenti
memori
cell
cell
produc
tend
shortliv
thu
presum
antigenactiv
cell
migrat
lymphoid
tissu
lung
belong
effect
organ
shortliv
memori
cell
resid
lymphoid
tissu
addit
potenti
import
cytokineproduc
cell
hlaa
restrict
peptidespecif
cell
identifi
base
abil
express
two
intracellular
protein
normal
found
lysosom
also
structur
compon
cytotox
granul
acquisit
cell
surfac
associ
loss
intracellular
perforin
indic
exposur
cell
surfac
depend
degranul
follow
exocytosi
cytotox
granul
transient
express
cell
surfac
ctl
thu
express
actual
reflect
cytotox
abil
antigenspecif
cell
kamath
et
al
detect
level
antigenspecif
cell
mycobacterium
tuberculosi
infect
howev
express
antigenspecif
cell
sar
never
detect
result
show
first
time
express
peptid
stimul
lymphocyt
spleen
markedli
increas
suggest
product
cytotox
antigenspecif
cell
vaccin
tg
mice
meanwhil
detect
coexpress
respect
interestingli
data
demonstr
popul
cell
produc
could
observ
fig
data
impli
measur
cell
respons
product
alon
previou
studi
may
underestim
total
respons
varieti
antigenspecif
cell
vivo
base
product
express
found
greater
frequenc
peptidespecif
cell
local
lung
major
target
site
sar
human
wherea
secondli
spleen
frequenc
peptidespecif
cell
lymph
node
lower
spleen
low
detect
level
fig
data
consist
previou
report
indic
hepat
b
viru
mous
model
time
point
greatest
frequenc
specif
cell
found
liver
although
spleen
largest
number
antigenspecif
cell
thu
would
valu
determin
immun
whether
phenotyp
function
differ
antigenspecif
memori
cell
lymphoid
nonlymphoid
tissu
case
viral
infect
besid
investig
phenotyp
peptidespecif
cell
base
product
express
frequent
use
defin
memori
cell
express
decreas
effector
cell
compar
naiv
cell
wherea
memori
cell
like
naiv
cell
express
high
phenotyp
studi
express
molecul
high
produc
cell
presenc
naiv
phenotyp
cell
antigen
exposur
alreadi
observ
could
explain
reexpress
downregul
effector
phase
surfac
protein
mediat
home
lymphoid
organ
revers
vivo
alreadi
describ
fact
cm
express
rel
high
level
em
express
rel
low
level
molecul
observ
rather
popul
cell
low
central
memori
cell
high
result
similar
found
meraldi
v
demonstr
multim
cell
intermedi
phenotyp
high
high
low
induc
polypeptid
plasmodium
berghei
might
readi
conscript
effector
popul
reinfect
conclud
shown
hlaa
restrict
sar
epitopespecif
cell
could
protect
bodi
viral
infect
tg
mice
model
protect
mediat
cytolyt
repres
express
noncytolyt
mechan
latter
result
product
cell
distribut
peptidespecif
cell
memori
cell
characterist
differ
lymphoid
tissu
nonlymphoid
tissu
taken
togeth
data
provid
novel
inform
cellular
immun
respons
sar
antigenspecif
cell
import
develop
vaccin
sarscov
infect
therefor
hypothesi
sar
dna
prime
hlaa
restrict
peptid
boost
vaccin
may
offer
consider
potenti
human
prevent
vaccin
past
exposur
prophylaxi
china
help
mous
immun
work
support
grant
nation
project
conflict
interest
statement
author
conflict
interest
